Skip to main content
Start Project

Methodology

How GHMAP structures market-access intelligence.

GHMAP separates verified source context from open questions, placeholders, and professional-review requirements.

Start a projectRead the standards

Methodology

Source type, jurisdiction, date, and review status stay attached to every market-access record.

Source standards

7 standards every market-access record is held to

Each standard is applied at the record level, so a brief can never present an unsourced field as a conclusion.

01

Accepted source types

  • Official regulator publications
  • Government and ministry materials
  • Payer, HTA, and reimbursement guidance
  • Peer-reviewed literature where relevant to evidence context
  • Qualified local professional review notes
02

Source hierarchy

  • Primary official sources first
  • Current jurisdiction-specific guidance before summaries
  • Secondary sources used only with source status clearly marked
  • Unverified material remains labeled as source required or to be verified
03

Jurisdiction and date tagging

  • Country and sub-jurisdiction where applicable
  • Source date
  • Review date
  • Reviewer role or review status when available
  • Known update cadence or next review trigger when available
04

Confidence levels

  • High: primary source, current, jurisdiction-matched, reviewed
  • Medium: credible source but missing one or more verification dimensions
  • Low: incomplete, outdated, indirect, or not yet reviewed
  • Unknown: source required before business use
05

Human review process

  • AI-assisted structuring should be reviewed by qualified professionals
  • Market-access conclusions require human validation
  • Local counsel, regulatory specialists, reimbursement advisors, and commercial experts may be needed
06

AI limitations

  • AI can organize questions and draft comparison structures
  • AI may miss recent changes, local nuance, or source context
  • AI output is not a regulatory, reimbursement, clinical, legal, or commercial determination
07

Update frequency

  • Important sources should be rechecked before business decisions
  • Update cadence depends on jurisdiction, source type, and market activity
  • Older or undated materials should remain lower confidence until reviewed

Market-access workflow

Twelve stages. One reviewable path.

GHMAP keeps the same operating sequence from market research through scale. This page holds the detail; the homepage shows only the five-arc journey.

  1. 01

    Market Research

  2. 02

    Regulatory Review

  3. 03

    Pricing

  4. 04

    Partner Search

  5. 05

    Partner Qualification

  6. 06

    Demo/Pilot

  7. 07

    Registration

  8. 08

    Agreement

  9. 09

    Import

  10. 10

    Launch

  11. 11

    Track

  12. 12

    Scale

Stages describe structure, not completed deals, approvals, or launch outcomes. AI may help structure questions; it does not make regulatory, clinical, or commercial decisions.

Governance

What the methodology does not do

GHMAP organizes market-access questions. It does not replace the professional judgement that closes them.

01GHMAP structures source status, evidence gaps, review needs, and next actions for market-access planning.

02Professional review remains part of the workflow, including regulatory, reimbursement, legal, compliance, and commercial review where appropriate.

03Update frequency depends on the source and jurisdiction. Important materials should be rechecked before business decisions are made.

GHMAP does not provide diagnosis, treatment advice, legal advice, regulatory approval, reimbursement guarantees, or investment advice.

Reviewed launch planning

Put the methodology to work on your product and target country.

GHMAP structures source status, evidence gaps, review needs, and next actions for market-access planning.

Start a projectView sample brief

Professional review is required before business use.